NYSE:ZBH
Zimmer Biomet Holdings Stock News
$119.56
-0.720 (-0.599%)
At Close: May 01, 2024
PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?
12:40pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at the Diagnostics segment.
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
12:39pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
Zimmer Biomet (ZBH) to Report Q1 Earnings: What's in Store?
11:17am, Tuesday, 26'th Apr 2022
Zimmer Biomet (ZBH) might have struggled to maintain the recovery trend in the first half of Q1 with severe-than-expected staffing shortages and supply issues leading to procedural deferrals.
What's in Store for West Pharmaceutical's (WST) Q1 Earnings?
01:47pm, Monday, 25'th Apr 2022 Zacks Investment Research
West Pharmaceutical's (WST) first-quarter results are likely to reflect strength in the Proprietary Products business.
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
01:46pm, Monday, 25'th Apr 2022 Zacks Investment Research
DexCom's (DXCM) first-quarter results are likely to reflect rising global awareness of its real-time CGM.
3 Medical Product Stocks Poised to Beat This Earnings Season
11:54am, Monday, 25'th Apr 2022 Zacks Investment Research
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
3 Medical Product Stocks Poised to Beat This Earnings Season
09:02am, Monday, 25'th Apr 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
Baxter (BAX) to Report Q1 Earnings: What's in the Offing?
01:16pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Baxter's (BAX) first-quarter results are likely to reflect growth in its Acute Therapies business.
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock For Now
01:31pm, Monday, 18'th Apr 2022 Zacks Investment Research
Investors are optimistic about Zimmer Biomet (ZBH) given robust demand for its ROSA robotics line and continued investment in profitable business areas.
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock For Now
10:32am, Monday, 18'th Apr 2022
Investors are optimistic about Zimmer Biomet (ZBH) given robust demand for its ROSA robotics line and continued investment in profitable business areas.
Company News for Apr 6, 2022
12:37pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Companies In The News Are: ZBH, CCL, UNH, CHNG, BA.
Zimmer Biomet (ZBH) Hurt by China VBP, COVID-Led Staff Shortage
02:33pm, Monday, 04'th Apr 2022 Zacks Investment Research
Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.
Zimmer Biomet (ZBH) Hurt by China VBP, COVID-Led Staff Shortage
12:03pm, Monday, 04'th Apr 2022
Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.
7 Dividend Stocks to Avoid in the Rotation to Safety
03:41pm, Monday, 28'th Mar 2022
It's just as important to know what dividend stocks to avoid as it is to know which ones to buy, especially in the current market. The post 7 Dividend Stocks to Avoid in the Rotation to Safety appeare
Zimmer Biomet: Short-Term Issues, Long-Term Growth Opportunities
11:54am, Thursday, 24'th Mar 2022
Zimmer Biomet ( ZBH , Financial) is a global leader in musculoskeletal health care. The company designs, manufactures and markets orthopedic reconstructive implants and supplies surgical equipment for
